Navigation Links
Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
Date:6/25/2008

KIRKLAND, Wash., June 25 /PRNewswire/ -- Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), announced it was recently granted another patent for its Pathway PV(TM) Atherectomy System. The issuance of this latest patent enhances the intellectual property related to Pathway Medical's innovative atherectomy system, which is designed to treat the difficult arterial disease found in the legs. Pathway Medical has a total of three patents issued by the U.S. patent office relating to differential cutting and the removal of atherosclerotic plaque for its rotational atherectomy system.

"This latest patent is one more addition to a robust intellectual property portfolio covering key aspects of our system," said Ted Wulfman, CTO and co-founder of Pathway Medical. "We continue to pursue a strategy of building a strong intellectual property portfolio to protect the many inventions and systems related to this innovative atherectomy technology." Mr. Wulfman noted there are several other patents pending.

About Pathway Medical Technologies, Inc.

Pathway Medical Technologies, Inc. was founded to design, market and manufacture medical devices for the treatment of arterial disease. The company's initial focus is treating peripheral arterial disease (PAD) more quickly and effectively than existing technologies. An estimated 8-12 million people are afflicted by PAD in the U.S., and that number is projected to grow to over 20 million during the next 10 years. The company's Pathway PV(TM) Atherectomy System allows for a minimally invasive procedure designed to restore circulation in the peripheral arteries by removing both hard and soft diseased tissue. For further information, visit the company's Web site at http://www.pathwaymedical.com.


'/>"/>
SOURCE Pathway Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Penn researchers find key developmental pathway activates lung stem cells
2. Scientists ID Brain Pathway That Stops Seizures
3. Discovery of new signal pathway important to diabetes research
4. Researchers ID Inflammation-Fighting Pathway in Fat Cells
5. Major missed biochemical pathway emerges as important in virtually all cells
6. Embryonic pathway delivers stem cell traits
7. Embryonic Pathways Induce Stem Cell Traits
8. Immune system pathway identified to fight allergens, asthma
9. Breast cancer subtypes originate from different biological pathways
10. Stem Cell Marker Controls Pair of Key Cancer Pathways
11. Georgetown researchers find stem cell marker controls 2 key cancer pathways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: